As ASC administrators seek to make up ground lost to the COVID-19 shutdown, it’s critical to take full advantage of every opportunity to stretch marketing dollars and maximize conversion of prospective clients that walk through the door. While the short-term boom of procedures delayed during the COVID hiatus will help, administrators need to be thinking beyond the next 90 days. Now more than ever it is critical to minimize the number of the number of ineligible patients (and procedures) that are walking back out the door, particularly those that can be managed in ways that don’t negatively impact your business model.
A major area of ineligibility that can be successfully addressed along these lines is obesity and related comorbidities. With the most recent National Center for Health Statistics data (February 2020 data brief found here: https://www.cdc.gov/nchs/data/databriefs/db360-h.pdf) showing ~45% of Americans over 40 years of age are obese (BMI 30+) and 12% are severely obese (BMI 40+), there is little doubt the obesity epidemic is negatively affecting your ASC bottom line. If you extrapolate these statistics from the general population to the demographics of the most common ASC procedures the relevance is clear, add in common comorbidities like hypertension and type 2 diabetes and the likelihood grows even higher. So, how does a savvy ASC administrator overcome this challenge? By implementing strategies that turn ineligible patients into eligible patients (and procedures). An effective overall strategy to do just that focuses on three main steps: